The SMYD1 p.Asn101Ser is a partial loss-of-function variant that impairs mitochondrial function and leads to early-onset cardiomyopathy.
- DOI
- 10.64898/2026.07.28.741372
- Published
- 2026 Jul 31
- Container
- bioRxiv : the preprint server for biology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.64898/2026.07.28.741372,
title = {The SMYD1 p.Asn101Ser is a partial loss-of-function variant that impairs mitochondrial function and leads to early-onset cardiomyopathy.},
author = {Szulik MW and Gwynn C and Creed M and Ghaloul-Gonzalez L and Franklin S},
year = {2026},
journal = {bioRxiv : the preprint server for biology},
doi = {10.64898/2026.07.28.741372},
url = {https://doi.org/10.64898/2026.07.28.741372}
}RIS
TY - JOUR TI - The SMYD1 p.Asn101Ser is a partial loss-of-function variant that impairs mitochondrial function and leads to early-onset cardiomyopathy. AU - Szulik MW AU - Gwynn C AU - Creed M AU - Ghaloul-Gonzalez L AU - Franklin S PY - 2026 JO - bioRxiv : the preprint server for biology DO - 10.64898/2026.07.28.741372 UR - https://doi.org/10.64898/2026.07.28.741372 ER -
APA
MW, S., C, G., M, C., L, G., & S, F. (2026). The SMYD1 p.Asn101Ser is a partial loss-of-function variant that impairs mitochondrial function and leads to early-onset cardiomyopathy.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.07.28.741372
Source records
- pubmed · retrieved 2026-09-26T22:08:11.270Z